
Statins have been and continue to be the first-choice therapy options for patients, but the addition of Nexletol adds a different new dimension to managing this disease.

Statins have been and continue to be the first-choice therapy options for patients, but the addition of Nexletol adds a different new dimension to managing this disease.

New treatment options offer hopes of better clinical outcomes for patients suffering from Parkinson disease and its debilitating daily symptoms.

Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.

Options include Adakveo, Endari (L-glutamine oral powder), hydroxyurea (Droxia, Hydrea, Siklos), Oxbryta (voxelotor), as well as OTC medications, such as aspirin and ibuprofen.

The 2 most common, recommended, and simplified treatments for HCV are glecaprevir/pibrentasvir (Mavyret) and sofosbuvir/velpatasvir (Epclusa).

COVID-19 has spread to 180 countries and territories and includes and caused more than 44,000 so far, but this is not the first time a pandemic has occurred.

Health care providers often encounter patients with high blood pressure, especially systolic, who come and go without proper treatment and eventually end up in the hospital with a heart attack, kidney failure, or a stroke.